These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15339689)

  • 1. Molecular diagnosis of leukemic cerebrospinal fluid cells in children with newly diagnosed acute lymphoblastic leukemia.
    Scrideli CA; Queiroz RP; Takayanagui OM; Bernardes JE; Melo EV; Tone LG
    Haematologica; 2004 Aug; 89(8):1013-5. PubMed ID: 15339689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy.
    Szczepański T; Willemse MJ; Kamps WA; van Wering ER; Langerak AW; van Dongen JJ
    Med Pediatr Oncol; 2001 Mar; 36(3):352-8. PubMed ID: 11241436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia.
    Sayed D; Badrawy H; Ali AM; Shaker S
    Leuk Res; 2009 May; 33(5):655-61. PubMed ID: 18996593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction.
    Pine SR; Yin C; Matloub YH; Sabaawy HE; Sandoval C; Levendoglu-Tugal O; Ozkaynak MF; Jayabose S
    J Mol Diagn; 2005 Feb; 7(1):127-32. PubMed ID: 15681484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
    Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
    Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
    Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
    Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
    Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
    Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
    Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between expression of GYPC and TRIP3 genes and prognosis of acute lymphoblastic leukemia in children].
    Zhang JB; Li XH; Ning F; Guo XS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):29-32. PubMed ID: 19149918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
    Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
    Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia.
    Emerenciano M; Agudelo Arias DP; Coser VM; de Brito GD; Macedo Silva ML; Pombo-de-Oliveira MS;
    Pediatr Blood Cancer; 2006 Oct; 47(5):549-54. PubMed ID: 16261608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.